Nurses’ safety during cancer therapy must be a priority
Intended for healthcare professionals
Opinion Previous     Next

Nurses’ safety during cancer therapy must be a priority

Alison Simons Senior lecturer, pathway award leader, Haematology and cancer, school of health sciences, Birmingham City University
Samantha Toland Senior lecturer, Haematology, school of nursing and midwifery, Birmingham City University

Too many healthcare providers rely on only personal protective equipment for their staff

Nurses administering systemic anticancer therapy (SACT) agents are at risk of consistent exposure to hazardous drugs known to cause health hazards. Long and short-term effects have been noted as including nausea, headaches, dizziness, hair loss and fertility problems (Sessink 2016). They are often putting themselves at risk without adequate protection and awareness, and despite the existence of specific guidance, there are still major inconsistencies in practice that may leave nurses vulnerable to occupational exposure to these hazardous agents.

Cancer Nursing Practice. 18, 1, 14-14. doi: 10.7748/cnp.18.1.14.s14

Want to read more?

Already subscribed? Log in


Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now